Delia F. Tifrea Department of Pathology and Laboratory Medicine University of California Biography Publications Institution JoVE Articles Delia F. Tifrea has not added a biography. If you are Delia F. Tifrea and would like to personalize this page please email our Author Liaison for assistance. Publications Disruption of β-Catenin-Dependent Wnt Signaling in Colon Cancer Cells Remodels the Microenvironment to Promote Tumor Invasion Molecular Cancer Research : MCR. Mar, 2022 | Pubmed ID: 34799404 Induction of Protection in Mice Against a Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles Vaccines. Jul, 2021 | Pubmed ID: 34358171 Genome-Wide B Cell, CD4, and CD8 T Cell Epitopes That Are Highly Conserved Between Human and Animal Coronaviruses, Identified from SARS-CoV-2 As Targets for Preemptive Pan-Coronavirus Vaccines Journal of Immunology (Baltimore, Md. : 1950). 06, 2021 | Pubmed ID: 33911008 Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody Plus Disease Risk Factor Score MSphere. 04, 2021 | Pubmed ID: 33910993 Vaccination with the Recombinant Major Outer Membrane Protein Elicits Long-term Protection in Mice Against Vaginal Shedding and Infertility Following a Genital Challenge NPJ Vaccines. 2020 | Pubmed ID: 33083025 Induction of Protection in Mice Against a Respiratory Challenge by a Vaccine Formulated with Exosomes Isolated from Infected Cells NPJ Vaccines. 2020 | Pubmed ID: 33014435 Protection Against a Chlamydial Respiratory Challenge by a Chimeric Vaccine Formulated with the Major Outer Membrane Protein Variable Domains Using the Porin B As a Scaffold NPJ Vaccines. 2020 | Pubmed ID: 32411400 Improved Protection Against Chlamydia Muridarum Using the Native Major Outer Membrane Protein Trapped in Resiquimod-carrying Amphipols and Effects in Protection with Addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) Adjuvant Vaccine. 06, 2020 | Pubmed ID: 32386746 Protection of Outbred Mice Against a Vaginal Challenge by a Serovar E Recombinant Major Outer Membrane Protein Vaccine is Dependent on Phosphate Substitution in the Adjuvant Human Vaccines & Immunotherapeutics. 10, 2020 | Pubmed ID: 32118511 Rapid Bacterial Detection and Antibiotic Susceptibility Testing in Whole Blood Using One-step, High Throughput Blood Digital PCR Lab on a Chip. 02, 2020 | Pubmed ID: 31872202 A Recombinant Chlamydia Trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility The Journal of Infectious Diseases. 01, 2020 | Pubmed ID: 31504647 Characterization of the Horizontal and Vertical Sexual Transmission of Genital Infections in a New Mouse Model Infection and Immunity. 07, 2019 | Pubmed ID: 30833332 Co-delivery of Amphipol-conjugated Adjuvant with Antigen, and Adjuvant Combinations, Enhance Immune Protection Elicited by a Membrane Protein-based Vaccine Against a Mucosal Challenge with Chlamydia Vaccine. 10, 2018 | Pubmed ID: 30293763 Transcervical Inoculation with Chlamydia Trachomatis Induces Infertility in HLA-DR4 Transgenic and Wild-Type Mice Infection and Immunity. 01, 2018 | Pubmed ID: 29038126 Comparison of the Nine Polymorphic Membrane Proteins of Chlamydia Trachomatis for Their Ability to Induce Protective Immune Responses in Mice Against a C. Muridarum Challenge Vaccine. 05, 2017 | Pubmed ID: 28385608 The Cationic Liposomal Adjuvants CAF01 and CAF09 Formulated with the Major Outer Membrane Protein Elicit Robust Protection in Mice Against a Chlamydia Muridarum Respiratory Challenge Vaccine. 03, 2017 | Pubmed ID: 28238632 Computational Modeling of TC0583 As a Putative Component of the Chlamydia Muridarum V-type ATP Synthase Complex and Assessment of Its Protective Capabilities As a Vaccine Antigen Microbes and Infection. Apr, 2016 | Pubmed ID: 26706820 Increased Immunoaccessibility of MOMP Epitopes in a Vaccine Formulated with Amphipols May Account for the Very Robust Protection Elicited Against a Vaginal Challenge with Chlamydia Muridarum Journal of Immunology (Baltimore, Md. : 1950). Jun, 2014 | Pubmed ID: 24778450 Vaccination with Major Outer Membrane Protein Proteosomes Elicits Protection in Mice Against a Chlamydia Respiratory Challenge Microbes and Infection. Nov, 2013 | Pubmed ID: 23999313 Vaccination with the Recombinant Major Outer Membrane Protein Elicits Antibodies to the Constant Domains and Induces Cross-serovar Protection Against Intranasal Challenge with Chlamydia Trachomatis Infection and Immunity. May, 2013 | Pubmed ID: 23478318 Toll-like Receptor 2-dependent Activity of Native Major Outer Membrane Protein Proteosomes of Chlamydia Trachomatis Infection and Immunity. Jan, 2013 | Pubmed ID: 23132491 Amphipols Stabilize the Chlamydia Major Outer Membrane Protein and Enhance Its Protective Ability As a Vaccine Vaccine. Jun, 2011 | Pubmed ID: 21550371 Zellfreie skalierte Produktion und adjuvante Zugabe zu einem rekombinanten Haupt-Außenmembranprotein aus Chlamydia muridarum für die Impfstoffentwicklung Sean F. Gilmore*1, Wei He*1, Angela C. Evans1, Delia F. Tifrea2, Sukumar Pal2, Brent Segelke1, Sandra K. G. Peters1, B. Dillon Vannest1, Nicholas O. Fischer1, Amy Rasley1, Luis M. de la Maza2, Matthew A. Coleman1,3 1Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, 2Department of Pathology and Laboratory Medicine, University of California, 3School of Medicine, Radiation Oncology, University of California Davis JoVE 63028 Immunology and Infection
Zellfreie skalierte Produktion und adjuvante Zugabe zu einem rekombinanten Haupt-Außenmembranprotein aus Chlamydia muridarum für die Impfstoffentwicklung Sean F. Gilmore*1, Wei He*1, Angela C. Evans1, Delia F. Tifrea2, Sukumar Pal2, Brent Segelke1, Sandra K. G. Peters1, B. Dillon Vannest1, Nicholas O. Fischer1, Amy Rasley1, Luis M. de la Maza2, Matthew A. Coleman1,3 1Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, 2Department of Pathology and Laboratory Medicine, University of California, 3School of Medicine, Radiation Oncology, University of California Davis JoVE 63028 Immunology and Infection
